These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23 related articles for article (PubMed ID: 2747592)
1. A FOLLOW -UP STUDY OF CHILDREN AND ADOLESCENTS AT GOVERNOR BACON HEALTH CENTER'S PSYCHIATRIC DIVISION. GALLIANI CA; VOEGELE GE; DIETZE HJ Del Med J; 1963 Nov; 35():285-90. PubMed ID: 14081832 [No Abstract] [Full Text] [Related]
2. Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group. Pfreundschuh MG; Schoppe WD; Fuchs R; Pflüger KH; Loeffler M; Diehl V Cancer Treat Rep; 1987 Dec; 71(12):1203-7. PubMed ID: 2446751 [TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy for the treatment of Hodgkin's disease in relapse. Results with lomustine (CCNU), melphalan (Alkeran), and vindesine (DVA) alone (CAD) and in alternation with MOPP and doxorubicin (Adriamycin), bleomycin, and vinblastine (ABV). Straus DJ; Myers J; Koziner B; Lee BJ; Clarkson BD Cancer Chemother Pharmacol; 1983; 11(2):80-5. PubMed ID: 6194913 [TBL] [Abstract][Full Text] [Related]
4. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease. Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727 [TBL] [Abstract][Full Text] [Related]
6. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone. Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771 [TBL] [Abstract][Full Text] [Related]
7. [Results of the treatment of lymphogranulomatosis]. Kholin AV Ter Arkh; 1986; 58(2):143-7. PubMed ID: 2422774 [No Abstract] [Full Text] [Related]
8. Hodgkin's disease in children: correlation of clinical characteristics, staging procedures, and treatment at the University of Minnesota. McClain KL; Heise R; Day DL; Lee CK; Woods WG; Aeppli D Am J Pediatr Hematol Oncol; 1990; 12(2):147-54. PubMed ID: 1696073 [TBL] [Abstract][Full Text] [Related]
9. Can MOPP be replaced in the treatment of advanced Hodgkin's disease? Canellos GP Semin Oncol; 1990 Feb; 17(1 Suppl 2):2-6. PubMed ID: 1689509 [TBL] [Abstract][Full Text] [Related]
10. [Primary treatment of advanced Hodgkin's disease]. Illés A; Udvardy M; Molnár Z Orv Hetil; 2005 Jan; 146(5):195-202. PubMed ID: 15773586 [TBL] [Abstract][Full Text] [Related]
11. Malignant histiocytosis: therapeutic results in 27 children treated with a single polychemotherapy regimen. Brugieres L; Caillaud JM; Patte C; Rodary C; Bernard A; Kalifa C; Hartmann O; Lemerle J Med Pediatr Oncol; 1989; 17(3):193-6. PubMed ID: 2747592 [TBL] [Abstract][Full Text] [Related]